Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Enrollment completed in phase I colorectal cancer study of Cotara

Aug. 5, 2004

Cytovia researchers identify new caspase activators

Aug. 5, 2004

OSI completes Tarceva NDA filing in NSCLC

Aug. 4, 2004

Structural GenomiX acquires Troxatyl rights

Aug. 4, 2004

Synthetic indole compound effective against multidrug resistant tumors in vivo

Aug. 4, 2004

New tubulin polymerization inhibitors covered by Cytopia patent

Aug. 4, 2004

New cinnoline-based antitumor agents in early development at Nippon Kayaku

Aug. 4, 2004

Louisiana State University and Bionomics enter cancer gene therapy agreement

Aug. 3, 2004

Gemzar combination therapy receives European approvals for ovarian cancer

Aug. 2, 2004

Novel HDAC inhibitors in early development at Roche

Aug. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...